40 related articles for article (PubMed ID: 9558974)
1. Experimental studies on bacterial product CANTASTIM derived from Pseudomonas aeruginosa with immunomodulatory properties. IV. Tyrosine phosphorylation as an effect of stimulation on different cell populations.
Onu A; Stefanescu M; Matache C; Salageanu A; Istrate N; Szegli G
Roum Arch Microbiol Immunol; 1997; 56(1-2):37-45. PubMed ID: 9558974
[TBL] [Abstract][Full Text] [Related]
2. Experimental studies on bacterial product CANTASTIM derived from Pseudomonas aeruginosa. II. Protective effect in Salmonella typhimurium infection.
Salageanu A; Ceacareanu B; Popescu D; Istrate N; Szegli G
Roum Arch Microbiol Immunol; 1997; 56(1-2):17-26. PubMed ID: 9558972
[TBL] [Abstract][Full Text] [Related]
3. Experimental studies on the bacterial product CANTASTIM derived from Pseudomonas aeruginosa. III. Suppression of lipopolysaccharide-induced tumor necrosis factor alpha: are the lipid components involved?
Salageanu A; Ceacareanu B; Istrate N; Szegli G
Roum Arch Microbiol Immunol; 1997; 56(1-2):27-35. PubMed ID: 9558973
[TBL] [Abstract][Full Text] [Related]
4. Modulation of CD14 expression on human granulocytes by a bacterial product "Cantastim" derived from Pseudomonas aeruginosa.
Radu DL; Dolganiuc A; Istrate N; Szegli G; Olinescu A
Roum Arch Microbiol Immunol; 1997; 56(1-2):47-53. PubMed ID: 9558975
[TBL] [Abstract][Full Text] [Related]
5. Experimental studies on the bacterial product CANTASTIM derived from Pseudomonas aeruginosa. V. Protective effect in endotoxin shock.
Salageanu A; Szegli G
Roum Arch Microbiol Immunol; 1999; 58(2):101-9. PubMed ID: 11845449
[TBL] [Abstract][Full Text] [Related]
6. In vivo and in vitro effect of Cantastim, an immunomodulatory agent extracted from a highly pathogenic Pseudomonas aeruginosa strain.
Olinescu A; Hristescu S; Sålågeanu A; Manda G; Neagu M
Neoplasma; 1991; 38(1):119-28. PubMed ID: 1901383
[TBL] [Abstract][Full Text] [Related]
7. [A nonspecific immunostimulant effect with Cantastim on the cellular and humoral immune responses in mice evaluated by in vivo and in vitro tests].
Olinescu A; Hristescu S; Sălăgeanu A; Manda G; Neagu M
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1989; 34(4):325-36. PubMed ID: 2641194
[TBL] [Abstract][Full Text] [Related]
8. Cytokine profiling by multiplex immunoassay as an effective approach to assess immunomodulatory activity of bacterial product CANTASTIM.
Lerescu L; Tucureanu C; Caraş I; Sălăgeanu A
Roum Arch Microbiol Immunol; 2006; 65(1-2):53-8. PubMed ID: 17877111
[TBL] [Abstract][Full Text] [Related]
9. Peroxynitrite inhibits T lymphocyte activation and proliferation by promoting impairment of tyrosine phosphorylation and peroxynitrite-driven apoptotic death.
Brito C; Naviliat M; Tiscornia AC; Vuillier F; Gualco G; Dighiero G; Radi R; Cayota AM
J Immunol; 1999 Mar; 162(6):3356-66. PubMed ID: 10092790
[TBL] [Abstract][Full Text] [Related]
10. Experimental studies on bacterial product cantastim derived from Pseudomonas aeruginosa. VII. Activation of immune cells of healthy controls and cancer patients.
Caras I; Serbanescu IF; Grigorescu A; Salageanu A
Roum Arch Microbiol Immunol; 2005; 64(1-4):5-10. PubMed ID: 17405308
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the safety of cantastim in normal humans.
Olinescu A; Radu LD; Dolganiuc A; Istrate N; Muni IA
Roum Arch Microbiol Immunol; 1996; 55(3):183-92. PubMed ID: 9256020
[TBL] [Abstract][Full Text] [Related]
12. Bacterial product cantastim derived from Pseudomonas aeruginosa induces migration and maturation of dendritic cells.
Caraş I; Tucureanu C; Lerescu L; Sălăgeanu A
Roum Arch Microbiol Immunol; 2007; 66(1-2):5-9. PubMed ID: 18928056
[TBL] [Abstract][Full Text] [Related]
13. Induction of mast cell interactions with blood vessel wall components by direct contact with intact T cells or T cell membranes in vitro.
Brill A; Baram D; Sela U; Salamon P; Mekori YA; Hershkoviz R
Clin Exp Allergy; 2004 Nov; 34(11):1725-31. PubMed ID: 15544597
[TBL] [Abstract][Full Text] [Related]
14. Galectin-1 specifically modulates TCR signals to enhance TCR apoptosis but inhibit IL-2 production and proliferation.
Vespa GN; Lewis LA; Kozak KR; Moran M; Nguyen JT; Baum LG; Miceli MC
J Immunol; 1999 Jan; 162(2):799-806. PubMed ID: 9916701
[TBL] [Abstract][Full Text] [Related]
15. [Normalization of immune function following therapy with Cantastim in a case of chronic T-cell lymphatic leukemia (CTLL)].
Olinescu A; Hristescu S; Sălăgeanu A; Petrovici A; Grigoriu G
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1988; 33(3):281-8. PubMed ID: 3249900
[No Abstract] [Full Text] [Related]
16. Experimental studies on bacterial product cantastim derived from Pseudomonas aeruginosa. VI. Protection in tolerant mice.
Caraş I; Sălăgeanu A
Roum Arch Microbiol Immunol; 2004; 63(1-2):47-62. PubMed ID: 16295320
[TBL] [Abstract][Full Text] [Related]
17. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
[TBL] [Abstract][Full Text] [Related]
18. Immunomodulation activity of a Pseudomonas aeruginosa extract--cantastim.
Neguţ E; Szegli G; Peligrad I; Matache C; Olinescu A; Marx A
Arch Roum Pathol Exp Microbiol; 1985; 44(4):323-35. PubMed ID: 3939398
[No Abstract] [Full Text] [Related]
19. Tyrosine phosphorylation of Crk-associated substrate lymphocyte-type is a critical element in TCR- and beta 1 integrin-induced T lymphocyte migration.
Ohashi Y; Iwata S; Kamiguchi K; Morimoto C
J Immunol; 1999 Oct; 163(7):3727-34. PubMed ID: 10490968
[TBL] [Abstract][Full Text] [Related]
20. The Pseudomonas aeruginosa quorum-sensing molecule N-3-(oxododecanoyl)-L-homoserine lactone inhibits T-cell differentiation and cytokine production by a mechanism involving an early step in T-cell activation.
Ritchie AJ; Jansson A; Stallberg J; Nilsson P; Lysaght P; Cooley MA
Infect Immun; 2005 Mar; 73(3):1648-55. PubMed ID: 15731065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
